Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner.
Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society.
We support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact.
Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society.
We support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact.
Location: United Kingdom, England, Oxford
Employees: 51-200
Founded date: 1987
Investment Stage: Seed; Series A
Portfolio 203
| Date | Name | Website | Total Raised | Location |
| 12.02.2026 | Astut | astut.co.uk | - | - |
| 14.11.2025 | Scripta Th... | scriptatherapeutics.com | $12.05M | United Kin... |
| 01.11.2025 | Macrocosm | macrocosm.group | - | - |
| 01.11.2025 | Vivid Dx (... | vivid-dx.com | - | - |
| 01.11.2025 | Oxa | oxa.tech | $243M | United Kin... |
| 23.02.2025 | Mode Labs | modelabs.tech | - | - |
| 26.01.2025 | OpenClinic... | openclinical.net | - | - |
| 26.01.2025 | Greater Ch... | greaterchange.co.uk | - | United Kin... |
| 26.01.2025 | Nature-bas... | naturebasedinsights.com | - | - |
| 26.01.2025 | Global Pat... | eit-pathogena.com | - | - |
Show more
Persons 48
| Date | First Name | Last Name | Title | Location | |||
| - | Anna | Herzberg | Operations... | - | a*********... | - | |
| - | Clare | Huggard | Deputy Hea... | - | c*********... | - | |
| - | Claire | Hewitt | PA to CEO | - | c*********... | - | |
| - | Adam | Minshall | Senior Lic... | - | a*********... | - | |
| - | Viv | Parry | People &am... | - | c*****s@in... | - | |
| - | Amber | Harrison | Investor R... | - | a*********... | - | |
| - | Bethany | Bonwick | University... | - | b*********... | - | |
| - | Gurinder | Punn | Senior Pro... | - | g*********... | - | |
| - | Rachel | Wilson | Consulting... | - | r*********... | - | |
| - | Rebecca | Glenapp | Licensing ... | - | r*********... | - |
Show more
Mentions in press and media 30
| Date | Title | Description |
| 30.03.2026 | CWOW 2026: Cambridge’s life sciences showcase expands to Oxford & London | Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time. The Cambridge-Oxford-London corridor is widely regarded as one of th... |
| 03.12.2025 | ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model | ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced the peer-reviewed publication of Phase 2b trial results in The... |
| 16.11.2025 | Scripta Therapeutics Transforms Disease Treatment with $12M Investment | Scripta Therapeutics, an Oxford-based techbio startup, has raised $12 million in seed funding. This capital propels its innovative biology-first platform. The system leverages AI, advanced imaging, and patient-derived models. It precisely t... |
| 14.11.2025 | Scripta Therapeutics Raises $12M in Seed Funding | Scripta Therapeutics, an Oxford, UK-based techbio startup, raised $12m in seed funding. The round was led by Oxford Science Enterprises and Apollo Health Ventures, with participation from AlbionVC, YZR Capital, and Parkwalk Advisors, and su... |
| 12.11.2025 | The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discovery | Oxford BioTech startup Scripta Therapeutics emerges from stealth today by announcing a €10.3 million ($12 million) Seed round to upend conventional approaches to drug discovery. The round is led jointly by Oxford Science Enterprises (OSE) a... |
| 23.09.2025 | DaltonTx Raises £4M in Seed Financing | DaltonTx, a London, UK-based provider of a disease- and technology-agnostic adaptive platform, raised £4M in Seed funding. Backers included redalpine, IQ Capital Partners, and Seedcamp, and support from Oxford University Innovation. The com... |
| 23.09.2025 | DaltonTx lands £4M to advance the intelligence backbone of drug discovery | UK-based technology company DaltonTx has exited stealth and completed a £4 million seed financing round. Backed by Redalpine, IQ Capital Partners, and Seedcamp, with additional support from Oxford University Innovation, DaltonTx will use th... |
| 09.09.2025 | MCatalysis: Seed Funding Raised For Microwave Catalysis Technology | MCatalysis, a deep tech startup focused on sustainable fuels and chemicals, has announced the closing of its seed funding round led by HL Energy Ventures (HLEV). The funding will advance the development and commercialization of MCatalysis’s... |
| 29.08.2025 | British startup Palmer Energy Technology acquires Brill Power in merger backed by €5.7 million raise | UK-based Palmer Energy Technology Limited (PETL), a battery energy storage system startup, has acquired Oxford University spin-out Brill Power in a strategic move to bolster its position in the Battery Energy Storage Systems (BESS) market. ... |
| 29.08.2025 | Palmer Energy Technology acquires battery tech firm Brill Power and secures £5M in funding | UK-based Palmer Energy Technology Limited (PETL), a battery energy storage system startup, has announced the acquisition of Brill Power, a spin-out from the University of Oxford known for its advanced battery management technology. The deal... |
Show more